Search results for "Cognition Disorders"

showing 7 items of 277 documents

Impact of pharmacological and psychological treatment methods of depressive and anxiety disorders on cognitive functioning

2014

Anxiety and depressive disorders are characterized by a number of clinical symptoms like decreased mood, apathy, anhedonia and anxiety. An important element of the clinical picture is also neurocognitive impairment. The most common treatment methods for depression and anxiety are pharmacology, psychotherapy or a combination of both methods. The data from literature show that those treatment methods lead to an improvement of clinical symptoms, but they exert a possible impact on cognitive functions. However the study results referring both to the role of pharmacological treatment and psychotherapy in this domain are still inconsistent. There is an increasing number of accessible data confirm…

medicine.medical_specialtyNeurologyClinical NeurologyPsychological interventionAnxietyPsychiatry and Preclinical Psychiatric Studies - Review articlemedicineHumansApathyCognitive skillPsychiatryBiological PsychiatryPsychotropic DrugsDepressionAnhedoniaCognitionAnxiety DisordersDatabases BibliographicPharmacotherapyCognitive functionsPsychotherapyPsychiatry and Mental healthNeurologyAnxietyNeurology (clinical)medicine.symptomCognition DisordersPsychologyNeurocognitiveClinical psychologyJournal of Neural Transmission : Translational Neuroscience, Neurology and Preclinical Neurological Studies, Psychiatry and Preclinical Psychiatric Studies
researchProduct

The capacity to consent to treatment in amyotrophic lateral sclerosis: a preliminary report

2020

Background: Facing the relentless worsening of their condition, ALS patients are required to make decisions on treatments and end-of-life care. A cognitive impairment showed to be a negative prognostic factor in ALS patients, perhaps affecting the ability to make informed decisions. Notwithstanding its crucial role, the capacity to consent to treatment (CCT) has never been evaluated in these patients. Objectives: To assess the CCT in an ALS cohort in comparison to a control group, and to study the effects of demographic and clinical variables on this high-level cognitive function. Methods: 102 ALS patients and 106 healthy controls (HC) were enrolled. CCT was assessed using the MacArthur Com…

medicine.medical_specialtyNeurologygenetic structuresDiseaseNeuropsychological TestsAffect (psychology)03 medical and health sciencesCognition0302 clinical medicinemedicineHumans030212 general & internal medicineAmyotrophic lateral sclerosisAmyotrophic lateral sclerosiDepression (differential diagnoses)Informed Consentbusiness.industryAmyotrophic Lateral SclerosisNeuropsychologyCognitionmedicine.diseaseeye diseases3. Good healthCognitive impairmentNeurologyCohortNeuropsychological Testsense organsNeurology (clinical)Cognition Disordersbusiness030217 neurology & neurosurgeryDecision-makingHumanClinical psychologyJournal of Neurology
researchProduct

A systematic review of neuropsychiatric symptoms in mild cognitive impairment.

2009

Mild cognitive impairment (MCI) is a clinical concept proposed as an intermediate state between normal aging and dementia. This condition has multiple heterogeneous sources, including clinical presentation, etiology, and prognosis. Recently, the prevalence and associated features of neuropsychiatric symptoms (NPS) in MCI have been described. We systematically searched the PubMed database (last accessed on August 31, 2008) for articles on NPS in MCI. Included articles used strict selection criteria, and outcome variables were extracted in duplicate; of the 27 articles included, 14 (52%) used prospective cohorts. The global prevalence of NPS in MCI ranged from 35% to 85%. The most common beha…

medicine.medical_specialtyPopulationDiseaseNeuropsychological TestsIrritabilitybehavioral disciplines and activitiesAlzheimer DiseaseRisk FactorsInternal medicinemental disordersmedicineDementiaAlzheimer’s disease behavior dementia depression incidence mild cognitive impairment neuropsychiatric symptoms predictors prevalence risk factorsHumansProspective cohort studyeducationDepression (differential diagnoses)education.field_of_studyClinical Trials as TopicGeneral NeuroscienceMental DisordersGeneral Medicinemedicine.diseasePsychiatry and Mental healthClinical PsychologyEtiologyAnxietySettore MED/26 - NeurologiaGeriatrics and Gerontologymedicine.symptomPsychologyCognition DisordersClinical psychologyJournal of Alzheimer's disease : JAD
researchProduct

S2k guidelines for Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) – update 2018

2019

Merkel cell carcinoma (MCC, ICD-O M8247 / 3) is a rare malignant primary skin tumor with epithelial and neuroendocrine differentiation. The neoplastic cells share many morphological, immunohistochemical and ultrastructural characteristics with Merkel cells of the skin. The diagnosis of MCC is rarely made on clinical grounds. Histological and immunohistochemical studies are usually required to confirm the clinical suspicion. Given the frequent occurrence of occult lymph node metastasis, sentinel lymph node biopsy should be performed once distant metastasis has been ruled out by cross-sectional imaging. Primary tumors without evidence of organ metastases are treated with complete surgical exc…

medicine.medical_specialtySkin Neoplasmsmedicine.medical_treatmentSentinel lymph nodeMedizinAntineoplastic AgentsDermatologyNeuroendocrine differentiation030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineBiopsyCarcinomaHumansMedicineNeoadjuvant therapyAgedNeoplasm Stagingmedicine.diagnostic_testbusiness.industryMerkel cell carcinomaPrognosismedicine.diseaseNeoadjuvant TherapyCarcinoma Merkel CellRadiation therapymedicine.anatomical_structureLymphatic MetastasisImmunotherapyRadiologyNeoplasm Recurrence LocalCognition DisordersbusinessMerkel cell
researchProduct

Innovation in Neurosurgery: The Concept of Cognitive Mapping

2019

In recent years, advances in cortical-subcortical mapping, intraoperative neurophysiology, and neuropsychology have increased the ability to remove intrinsic brain tumors, expanding indications and maximizing the extent of resection. This has provided a significant improvement in progression-free survival, time of malignant transformation (in low-grade gliomas), and overall survival. Although current techniques enable preservation of language and motor functions during surgery, the maintenance of a complex set of functions defined with the term cognition is not always achievable. Cognition is defined as every neural process underlying a high human function and includes motor haptic and visu…

medicine.medical_specialtymedia_common.quotation_subjectElectric Stimulation TherapyEmpathyNeurosurgical ProceduresExecutive Function03 medical and health sciencesPostoperative ComplicationsSpatial ProcessingCognition0302 clinical medicineQuality of life (healthcare)HumansGlioma surgeryMedicineCognitive rehabilitation therapySet (psychology)media_commonBrain MappingCognitive mapBrain Neoplasmsbusiness.industryEloquent areaNeuropsychologyMargins of ExcisionCognitionGliomaSemantics030220 oncology & carcinogenesisNeuropsychological testsSurgeryNeurology (clinical)NeurosurgeryCognition DisordersbusinessOrgan Sparing Treatments030217 neurology & neurosurgeryCognitive psychologyWorld Neurosurgery
researchProduct

EFFICACY OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION/TRANSCRANIAL DIRECT CURRENT STIMULATION IN COGNITIVE NEUROREHABILITATION

2008

Summary: Cognitive deficits are a common consequence of neurologic disease, in particular, of traumatic brain injury, stroke, and neurodegenerative disorders, and there is evidence that specific cognitive training may be effective in cognitive rehabilitation. Several investigations emphasize the fact that interacting with cortical activity, by means of cortical stimulation, can positively affect the short-term cognitive performance and improve the rehabilitation potential of neurologic patients. In this respect, preliminary evidence suggests that cortical stimulation may play a role in treating aphasia, unilateral neglect, and other cognitive disorders. Several possible mechanisms can accou…

medicine.medical_treatmentBiophysicsLANGUAGE050105 experimental psychologylcsh:RC321-57103 medical and health sciences0302 clinical medicinemedicineHumans0501 psychology and cognitive sciencesCognitive rehabilitation therapylcsh:Neurosciences. Biological psychiatry. NeuropsychiatryNeurorehabilitationCerebral CortexRehabilitationTranscranial direct-current stimulationSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaGeneral NeuroscienceTRANSCRANIAL DIRECT CURRENT STIMULATION05 social sciencesMEMORYATTENTIONCognitionCOGNITIVE REHABILITATIONTranscranial Magnetic StimulationCognitive trainingTranscranial magnetic stimulationTreatment OutcomeCOGNITIVE DEFICITSBrain stimulationREPETITIVE TRANSCRANIAL MAGNETIC STIMULATIONTranscutaneous Electric Nerve StimulationNeurology (clinical)PsychologyCognition DisordersNeuroscience030217 neurology & neurosurgery
researchProduct

Walking Stroop carpet: an innovative dual-task concept for detecting cognitive impairment

2013

A Perrochon,1,2,5 G Kemoun,1,2 E Watelain,3,4 A Berthoz51ISIS, Research Institute on Handicap and Aging, Paris; 2Université de Poitiers, Laboratoire Mobilité, Vieillissement et Exercice (MOVE), EA 6314, 3Université de Valenciennes, LAMIH, UMR CNRS 8201, 4Université Sud Toulon Var, HandiBio, EA 4322, La Garde, 5LPPA, UMR CNRS 7152, Collège de France, Paris, FranceBackground: Several studies have reported the potential value of the dual-task concept during locomotion in clinical evaluation because cognitive decline is strongly associated with gait abnormalities. However, current dual-task tests appear to be insufficient for early diagnosi…

mild cognitive impairment.AdultMalemedicine.medical_specialty[SDV]Life Sciences [q-bio]Neuropsychological TestsSensitivity and Specificitybehavioral disciplines and activities050105 experimental psychologyDevelopmental psychologyTask (project management)03 medical and health scienceswalking0302 clinical medicineGait (human)Physical medicine and rehabilitationmild cognitive impairmentmedicineCluster AnalysisHumans0501 psychology and cognitive sciencesCognitive declineCognitive impairmentdual-taskGait Disorders NeurologicComputingMilieux_MISCELLANEOUSAgedOriginal ResearchAged 80 and overAnalysis of Variancestroop[SCCO.NEUR]Cognitive science/Neuroscience05 social sciencesRC952-954.6[SDV.NEU.SC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive SciencesGeneral MedicineDUAL (cognitive architecture)Middle AgedGeriatricsClinical Interventions in AgingFemaleGeriatrics and GerontologyPsychologyCognition DisordersClinical evaluation030217 neurology & neurosurgeryPsychomotor Performancepsychological phenomena and processesStroop effect
researchProduct